Elon Musk's Neuralink Seeks , Approval to Begin Human Trials.
On November 30, Elon Musk said that his
Neuralink brain chip will begin human trials
sometime in the next six months.
'The Guardian' reports that
Musk made the announcement at
a presentation for his company, Neuralink.
'The Guardian' reports that
Musk made the announcement at
a presentation for his company, Neuralink.
Musk also said that he plans
on getting one of the chips installed himself.
We want to be extremely careful
and certain that it will work well
before putting a device into a human, Elon Musk, via 'The Guardian'.
According to Neuralink, the technology could be
used to restore a person's vision or return "full body
functionality" to someone with a severed spinal cord.
.
'The Guardian' points out that Neuralink
does not yet have approval from the Food and Drug
Administration (FDA) to sell the device.
'The Guardian' points out that Neuralink
does not yet have approval from the Food and Drug
Administration (FDA) to sell the device.
However, Musk said that most
of the paperwork seeking approval
has been submitted to the FDA.
The progress at first, particularly
as it applies to humans, will seem
perhaps agonizingly slow, but we are doing
all of the things to bring it to scale in parallel, Elon Musk, via 'The Guardian'.
So, in theory, progress
should be exponential, Elon Musk, via 'The Guardian'.
So, in theory, progress
should be exponential, Elon Musk, via 'The Guardian'.
Currently, Neuralink is continuing with
animal trials while it awaits approval
to begin testing its device on humans
Elon Musk and co. are making a major change to Twitter starting this month -- and it's going affect just about every verified celeb out there ... many of whom.. TMZ.com
LeBron James -- a billionaire -- says Elon Musk can't get him to shell out $8 a month to keep his Twitter verification ... admitting he's simply too cheap to.. TMZ.com
Italy Bans OpenAI's ChatGPT , and Launches Data Protection Investigation .
BBC reports that Italy
has become the first Western
country to ban ChatGPT.
According to the Italian data-protection
authority, U.S. startup OpenAI's model
has led to privacy concerns. .
The Italian regulator said it would
ban the app and investigate
OpenAI "with immediate effect.".
BBC reports that since its launch
in November of 2022, millions
of people have used ChatGPT.
The advanced chatbot, in which Microsoft has
invested billions, can answer questions using natural,
human-like language and mimic various writing styles.
Microsoft has said that it plans to embed a version
of the OpenAI technology in its Office apps,
including Word, Excel and PowerPoint.
Critics claim that artificial intelligence comes
with a number of potential risks, such as a threat
to job security and the spread of misinformation.
Key tech figures, including Elon Musk, called for
AI systems to be suspended amid fears that the
race to develop the technology is out of control.
Key tech figures, including Elon Musk, called for
AI systems to be suspended amid fears that the
race to develop the technology is out of control.
According to Italy's data-protection authority, it will block
OpenAI's chatbot but also determine whether the model is
in compliance with General Data Protection Regulation.
The authority claims there is no legal basis that justifies , "the mass collection and storage of personal data
for the purpose of 'training' the algorithms
underlying the operation of the platform."
Credit: Wibbitz Top Stories Duration: 01:31Published
Neil deGrasse Tyson is amused by Elon Musk and others who think AI technology is a threat to humanity ... he thinks the doomsday bunch are watching too many.. TMZ.com
FDA Weighs Authorization , of Second Round of , COVID Boosters for Some People.
The United States Food and Drug
Administration (FDA) is planning an annual
COVID booster campaign starting this fall.
NPR reports that the new round of boosters
will be updated to combat whatever variant is
expected to circulate in the following winter.
Currently, the FDA has only authorized
one booster of the latest bivalent vaccines. .
However, NPR reports that the FDA is reconsidering
its stance and weighing the authorization of
a second bivalent booster for some people.
According to an anonymous federal official, those being
considered for a second booster include people with
compromised immune systems or who are 65 and older.
Those doses are going to be expiring
and will be thrown out. So it makes sense
to have those shots in arms instead
of being tossed in the waste basket, Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine, via NPR.
Historically, when you look at the monovalent
vaccines, the protection starts to wane
after four or five months. We don't know
if that's the case with bivalent booster.
But you don't want to find out the hard way, Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine, via NPR.
Historically, when you look at the monovalent
vaccines, the protection starts to wane
after four or five months. We don't know
if that's the case with bivalent booster.
But you don't want to find out the hard way, Dr. Peter Hotez, co-director of the Texas Children's Hospital Center for Vaccine Development and dean of the National School of Tropical Medicine at Baylor College of Medicine, via NPR.
NPR reports that opponents of the second round
of boosters say there is not enough evidence to
show that protection has significantly faded.
I have no data to show me that
a second bivalent is safe and effective.
I have every reason to think it might be.
But I don't actually have data, Dr. Gregory Poland, director of the Mayo
Clinic's Vaccine Research Group, via NPR.
I have no data to show me that
a second bivalent is safe and effective.
I have every reason to think it might be.
But I don't actually have data, Dr. Gregory Poland, director of the Mayo
Clinic's Vaccine Research Group, via NPR.
NPR reports that there is also a chance that the shots
could have an opposite effect, as the bivalent boosters
target an old strain that has since been replaced.
Credit: Wibbitz Top Stories Duration: 01:31Published
FDA Approves , Over-the-Counter , Overdose Medication.
On March 29, the United States Food
and Drug Administration (FDA) approved overdose
reversal drug Narcan for over-the-counter use.
ABC reports that the decision marks
a milestone that advocates say will
save lives amid the ongoing opioid crisis.
Narcan is made by
Emergent BioSolutions.
The drug is a nasal spray containing naloxone, which can restore breathing if someone is experiencing an opioid overdose. .
According to medical experts, it is safe to administer
the drug to anyone who appears to be having an overdose,
even if it turns out they are not overdosing.
With the FDA's approval, the medication can now
be sold in places like drug stores, grocery stores,
convenience stores and even online.
With the FDA's approval, the medication can now
be sold in places like drug stores, grocery stores,
convenience stores and even online.
Today's approval of OTC naloxone nasal
spray will help improve access to naloxone,
increase the number of locations where
it's available and help reduce opioid
overdose deaths throughout the country, Dr. Robert M. Califf, FDA Commissioner, via ABC.
We encourage the manufacturer to make
accessibility to the product a priority by
making it available as soon as possible
and at an affordable price, Dr. Robert M. Califf, FDA Commissioner, via ABC.
According to the Centers for Disease Control
and Prevention, an estimated 107,622 drug
overdose deaths occurred in 2021, setting a record high.
ABC reports that a majority of those
deaths were the result of opioids, particularly
synthetic forms of opioids like fentanyl.
Credit: Wibbitz Top Stories Duration: 01:31Published
2 More Eyedrop Brands , Have Been Recalled.
ABC News reports that the FDA has posted recall notices for eyedrops distributed by Pharmedica and Apotex.
ABC News reports that the FDA has posted recall notices for eyedrops distributed by Pharmedica and Apotex.
Pharmedica said it is recalling
Purely Soothing 15% MSM Drops for issues
"that could result in blindness.".
The OTC eyedrops are intended
to soothe eye irritation.
That recall affects
approximately 2,900 bottles.
Apotex recalled Brimonidine Tartrate Ophthalmic Solution 0.15%.
The eyedrops treat a form of glaucoma.
No injuries have been reported, but the recall was issued after cracks were found in several caps.
The two recalls come after
EzriCare Artificial Tears were recalled last month.
In that instance, five people suffered permanent vision loss and one person died
Credit: Wibbitz Top Stories Duration: 01:30Published
Walgreens to Stop , Selling Abortion Pills , by Mail in 20 States.
On March 2, one of America's largest
pharmacies said it would not distribute
abortion pills by mail in some states.
On March 2, one of America's largest
pharmacies said it would not distribute
abortion pills by mail in some states.
CBS reports that Walgreens confirmed the decision
to stop dispensing Mifepristone, stating that
the abortion drug will no longer be available in 20 states.
CBS reports that Walgreens confirmed the decision
to stop dispensing Mifepristone, stating that
the abortion drug will no longer be available in 20 states.
According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion
drugs would violate both state and federal laws.
According to a letter dated February 1, Walgreens was warned by 20 attorneys general that the sale of abortion
drugs would violate both state and federal laws.
Last summer, following the overturning of Roe v. Wade,
Missouri was among several states to
implement strict prohibitions on abortion. .
Other states that Mifepristone will
no longer be available in include
Arkansas, Florida, Texas and West Virginia.
Other states that Mifepristone will
no longer be available in include
Arkansas, Florida, Texas and West Virginia.
We will only dispense in those
jurisdictions where it is legal
to do if we are certified, Walgreens, via statement.
CBS reports that over half
of all abortions in the U.S.
utilize Mifepristone.
For over 20 years, the FDA limited
the dispensing of the drug
due to safety concerns. .
For over 20 years, the FDA limited
the dispensing of the drug
due to safety concerns. .
Those restrictions were lifted amid
the COVID pandemic as a means of eliminating
the need for in-person appointments.
CBS reports that at least one lawsuit has been
filed against the FDA, claiming the agency
overstepped its authority in approving Mifepristone.
CBS reports that at least one lawsuit has been
filed against the FDA, claiming the agency
overstepped its authority in approving Mifepristone
Credit: Wibbitz Top Stories Duration: 01:30Published
145,000 Cans of Enfamil ProSobee , Infant Formula Recalled.
CNN reports that two batches of the company's plant-based formula have been recalled by one of its manufacturers, Reckitt.
The formula was possibly cross-contaminated with Cronobacter sakazakii bacteria.
According to Reckitt, the cause
“was linked to a material from a third party.”.
The company has taken “all appropriate corrective actions, including no longer sourcing this material from the supplier.”.
So far, product tests have come back negative for the bacteria and illnesses have not been reported. .
The recalled 12.9-ounce cans have a
use-by date of March 1, 2024.
They also contain the codes
ZL2HZF or ZL2HZZ.
CNN reports that while Cronobacter
infections are rare, they can be fatal.
The bacteria caused the recall of
Abbott Nutrition formula in 2022 which contributed to a nationwide shortage. .
The FDA says it's devising a plan to better detect Cronobacter in baby formula
Credit: Wibbitz Top Stories Duration: 01:31Published
Elon Musk has demonstrated new Neuralink technology with an interface between a computer and Monkees. The technology is raising new ethical concerns and raises questions about both human and animal..
Neuralink…a medical device company of Elon Musk is under federal investigation for potential animal-welfare violations. There have been internal staff complaints that its animal testing is being..
Neuralink Is Reportedly Being Investigated , Over Animal Testing.
Neuralink Is Reportedly Being Investigated , Over Animal Testing.
Engadget reports that according to
internal documents obtained by..
Credit: Wibbitz Top Stories Duration: 01:30Published